ArticleJTO clinical and research reports2025

Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study.

Byoung Chul Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.